fig7

<i> ADAM9</i> in cancer: a comprehensive analysis of mutation, prognostic value, expression and TQFL12-induced inhibition

Figure 7. TQFL12 inhibits the expression of ADAM9 in different cancer cell types. (A). TQFL12 inhibits ADAM9 protein in the 22RV1 cell line; (B) ADAM9 mRNA expression after TQFL12 treatment in the 22RV1 cell line; (C) TQFL12 inhibits ADAM9 protein in the MDA-MB-231 cell line; (D) ADAM9 mRNA expression after TQFL12 treatment in the MDA-MB-231 cell line; (E) TQFL12 inhibits ADAM9 protein in the H1975 cell line; (F) ADAM9 mRNA expression after TQFL12 treatment in the H1975 cell line. The β-actin protein or the ACTB gene were used as loading controls.

Journal of Translational Genetics and Genomics
ISSN 2578-5281 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/